Current molecular studies have delivered quite a few insights into the procedures that govern the event and progression of CLL, which includes several novel mutated genes clustered in different purposeful pathways. The CLL epigenome is reprogrammed through the modulation of regulatory locations that seem de novoSomatic mutations in chromatin remode